{"disease":{"id":"epithelial-ovarian-cancer","name":"epithelial ovarian cancer"},"drugs":{"marketed":[{"drug_id":"bevacizumab-maly","indication_name":"Platinum-Resistant Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ALYMSYS","generic_name":"BEVACIZUMAB-MALY","company_name":"AMNEAL PHARMS LLC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06223763","title":"SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT05801263","title":"ctDNA Methylation for Epithelial Ovarian Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT04027868","title":"Genomic BRCA and Extensive ovArian Cancer Testing","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"ARCAGY/ GINECO GROUP","has_results":false},{"nct_id":"NCT04152499","title":"Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1410,"lead_sponsor_name":"Klus Pharma Inc.","has_results":false},{"nct_id":"NCT05801276","title":"ctDNA Methylation for Detecting Ovarian Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":1400,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06366997","title":"Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test","phase":"","overall_status":"COMPLETED","enrollment_count":1352,"lead_sponsor_name":"Chongqing University Cancer Hospital","has_results":false},{"nct_id":"NCT04190667","title":"Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":1300,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06483399","title":"Research on Nutritional Risk Indexes and Inflammatory Indicators in Postoperative Complications and Prognosis of Epithelial Ovarian Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1108,"lead_sponsor_name":"Qinglei Gao","has_results":false},{"nct_id":"NCT07218809","title":"AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03522246","title":"A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1097,"lead_sponsor_name":"pharmaand GmbH","has_results":true},{"nct_id":"NCT06085456","title":"Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT06086665","title":"The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":850,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT02406235","title":"Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":710,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07528911","title":"Elements of Adaptive Immunity in Epithelial Ovarian Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":687,"lead_sponsor_name":"Hellenic Cooperative Oncology Group","has_results":false},{"nct_id":"NCT04498117","title":"Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":615,"lead_sponsor_name":"CanariaBio Inc.","has_results":false},{"nct_id":"NCT05870748","title":"REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":600,"lead_sponsor_name":"Sutro Biopharma, Inc.","has_results":false},{"nct_id":"NCT03740464","title":"Long-acting G-CSF for Febrile Neutropenia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":556,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06915025","title":"Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Imunon","has_results":false},{"nct_id":"NCT04191252","title":"Genetic Mutation in Epithelial Ovarian Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT01891344","title":"A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":491,"lead_sponsor_name":"pharmaand GmbH","has_results":true},{"nct_id":"NCT04209855","title":"A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":453,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05867251","title":"Study of AVZO-021 in Patients With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":430,"lead_sponsor_name":"Avenzo Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05172310","title":"PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":410,"lead_sponsor_name":"Karolinska University Hospital","has_results":false},{"nct_id":"NCT04823871","title":"Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing","phase":"NA","overall_status":"COMPLETED","enrollment_count":406,"lead_sponsor_name":"Paul Speiser, Prof.MD,","has_results":false},{"nct_id":"NCT04651946","title":"Cell-free DNA Methylation for Epithelial Ovarian Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05310370","title":"HRD and Resistance to PAPPi in EOC Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT04063527","title":"Phase III Trial of Stage I Ovarian Cancer After Surgery","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Japanese Gynecologic Oncology Group","has_results":false},{"nct_id":"NCT02855944","title":"ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":349,"lead_sponsor_name":"pharmaand GmbH","has_results":true},{"nct_id":"NCT04546373","title":"Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":316,"lead_sponsor_name":"Grupo Español de Investigación en Cáncer de Ovario","has_results":false},{"nct_id":"NCT03373058","title":"Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":310,"lead_sponsor_name":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","has_results":false},{"nct_id":"NCT04986371","title":"Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Ling-Ying Wu","has_results":false},{"nct_id":"NCT03862677","title":"Determining Prognostic Immune Markers in Patients With Ovarian Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT05310357","title":"Chromosomal Instability in Ovarian Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT01666444","title":"VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":297,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT04429542","title":"Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":292,"lead_sponsor_name":"Bicara Therapeutics","has_results":false},{"nct_id":"NCT04473339","title":"A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":280,"lead_sponsor_name":"CAI Hongbing","has_results":false},{"nct_id":"NCT04925284","title":"Study of XB002 in Subjects With Solid Tumors (JEWEL-101)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":269,"lead_sponsor_name":"Exelixis","has_results":false},{"nct_id":"NCT02606305","title":"Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":264,"lead_sponsor_name":"ImmunoGen, Inc.","has_results":true},{"nct_id":"NCT03180177","title":"Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":263,"lead_sponsor_name":"Shu-Zhong Cui","has_results":false},{"nct_id":"NCT05620134","title":"Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":263,"lead_sponsor_name":"Salubris Biotherapeutics Inc","has_results":false},{"nct_id":"NCT04794322","title":"Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT06673511","title":"The Application of Sentinel Lymph Node Mapping Technique in the Surgery of Early Epithelial Ovarian Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":246,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT04651920","title":"A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT03106987","title":"A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04651933","title":"A Training Set for the HRD Model in EOC","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06236958","title":"Effect of Early Enteral Nutrition on Postoperative Recovery of Ovarian Cancer Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Luo Chengyan","has_results":false},{"nct_id":"NCT04101760","title":"Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06582108","title":"UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":190,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT04802876","title":"Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":184,"lead_sponsor_name":"SOLTI Breast Cancer Research Group","has_results":false},{"nct_id":"NCT00408603","title":"Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":183,"lead_sponsor_name":"Sunesis Pharmaceuticals","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}